Karren H M Chen1, Victor W Henderson2, Renerus J Stolwyk1, Lorraine Dennerstein3, Cassandra Szoeke4. 1. School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia. 2. Departments of Health Research and Policy (Epidemiology) and of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA. 3. Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. 4. School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia Flory Institute of Neuroscience and Mental Health, Parkville, Melbourne, Victoria, Australia.
Abstract
BACKGROUND: previous studies raised the possibility that adverse health effects associated with elevated blood pressure (BP) begin at prehypertension levels (BP = 120-139/80-89 mmHg), yet few studies have examined the effects of prehypertension on cognitive functioning. OBJECTIVE: to examine the relationship between BP categories and cognitive functions in middle-aged and older women. SUBJECTS AND METHODS: two hundred and forty-seven women from the Women's Healthy Ageing Project had their BP measured twice, at mean ages 50 and 60 years. Tests of executive function, processing speed and verbal episodic memory were also administered at follow-up. Analyses of co-variance were performed to evaluate the associations between BP categories and cognitive performance. RESULTS: prehypertensive BP at age 50 years is a significant predictor of reduced processing speed and verbal episodic memory a decade later. Cross-sectional measurements at age 60 years showed that untreated hypertensive women performed significantly worse on verbal episodic memory compared with their prehypertensive peers. CONCLUSION: hypertension is a modifiable cardiovascular risk factor, and our results suggest that reducing midlife BP, even at prehypertensive levels, may be an effective prevention strategy to reduce risk for subsequent cognitive decline in middle-aged and older women.
BACKGROUND: previous studies raised the possibility that adverse health effects associated with elevated blood pressure (BP) begin at prehypertension levels (BP = 120-139/80-89 mmHg), yet few studies have examined the effects of prehypertension on cognitive functioning. OBJECTIVE: to examine the relationship between BP categories and cognitive functions in middle-aged and older women. SUBJECTS AND METHODS: two hundred and forty-seven women from the Women's Healthy Ageing Project had their BP measured twice, at mean ages 50 and 60 years. Tests of executive function, processing speed and verbal episodic memory were also administered at follow-up. Analyses of co-variance were performed to evaluate the associations between BP categories and cognitive performance. RESULTS: prehypertensive BP at age 50 years is a significant predictor of reduced processing speed and verbal episodic memory a decade later. Cross-sectional measurements at age 60 years showed that untreated hypertensivewomen performed significantly worse on verbal episodic memory compared with their prehypertensive peers. CONCLUSION:hypertension is a modifiable cardiovascular risk factor, and our results suggest that reducing midlife BP, even at prehypertensive levels, may be an effective prevention strategy to reduce risk for subsequent cognitive decline in middle-aged and older women.
Authors: Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri Journal: Hypertension Date: 2016-10-10 Impact factor: 10.190
Authors: Nanette K Wenger; Anita Arnold; C Noel Bairey Merz; Rhonda M Cooper-DeHoff; Keith C Ferdinand; Jerome L Fleg; Martha Gulati; Ijeoma Isiadinso; Dipti Itchhaporia; KellyAnn Light-McGroary; Kathryn J Lindley; Jennifer H Mieres; Mary L Rosser; George R Saade; Mary Norine Walsh; Carl J Pepine Journal: J Am Coll Cardiol Date: 2018-04-24 Impact factor: 24.094
Authors: Yin Ting Cheung; Michelle N Edelmann; Daniel A Mulrooney; Daniel M Green; Wassim Chemaitilly; Neena John; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-06-26 Impact factor: 4.254
Authors: J Richard Jennings; Matthew F Muldoon; Christopher Ryan; H Michael Gach; Alicia Heim; Lei K Sheu; Peter J Gianaros Journal: J Am Heart Assoc Date: 2017-03-17 Impact factor: 5.501
Authors: Jeffery M Reddan; David J White; Helen Macpherson; Andrew Scholey; Andrew Pipingas Journal: Front Aging Neurosci Date: 2018-03-07 Impact factor: 5.750
Authors: Yuichiro Yano; Michael Griswold; Wanmei Wang; Philip Greenland; Donald M Lloyd-Jones; Gerardo Heiss; Rebecca F Gottesman; Thomas H Mosley Journal: J Am Heart Assoc Date: 2018-08-07 Impact factor: 5.501